504 In 2007, researchers identified zinc transporter 8 autoantibodies (ZnT8A), 233 which have since been recognized as one of the four major islet autoantibodies along with GAD65 autoantibodies (GADA), 505 islet antigen-2 autoantibodies (IA-2A), 506 and insulin autoantibodies (IAA)
(J Neurosci, 2007) This is mechanistically distinct from GHK-Cu's neurotrophin pathway and may make TB-500 relevant in demyelinating contexts, though this remains highly speculative without human trials
GLP-1 agonists should not be prescribed for type 1 diabetes, during pregnancy, or with breastfeeding
If diarrhea occurs, ensure adequate hydration and electrolyte replacement
Have a History of Heart Disease: Some GLP-1 agonists have demonstrated cardiovascular benefits, reducing the risk of major adverse cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease
However, she made a specific exception for weight-loss drugs